Records containing: Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-10-15WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
-
CLINICAL_TRIALS study record update · 2025-10-14Young Adult Survivors United Cancer Research Registry
-
CLINICAL_TRIALS study record update · 2025-10-10Phase 1b, Randomized, Dose Optimization Study to Assess the Anti-Tumor Activity, Safety, and Pharmacokinetics of TLN-254 in Patients With Relapsed or Refractory T-cell Lymphoma
-
CLINICAL_TRIALS study record update · 2025-10-10Umbilical Cord Blood Transplantation From Unrelated Donors
-
CLINICAL_TRIALS study record update · 2025-10-09Evaluation of a Communication Intervention (Hematolo-GIST) for Large B-Cell Lymphoma Providers
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-10-03High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT): A Prospective Real-World Cohort Study in the Qinghai-Tibet Plateau
-
CLINICAL_TRIALS study record update · 2025-10-01Ofatumumab for Residual Disease and Maintenance Following Chemotherapy or Chemoimmunotherapy in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
-
CLINICAL_TRIALS study record update · 2025-09-30Research on AI-assisted Diagnosis of Common Malignant Brain Tumors Based on Magnetic Resonance Imaging
-
CLINICAL_TRIALS study record update · 2025-09-30International Phase II Study Evaluating the Association of CHOP-rituximab With Consolidation by Early Ibritumomab Tiuxetan-Y90 in Patients Aged 65 to 80 Years With CD20+ Large Cell Malignant Lymphoma and no Prior Therapy
-
CLINICAL_TRIALS study record update · 2025-09-29Remotely Monitored Rehabilitation in Hemato-oncological Survivors After Treatment: The Tele@Home Study
-
CLINICAL_TRIALS study record update · 2025-09-29Efficacy of the Web-based Return-to-school Adaptation Program for Children Diagnosed With Cancer
-
CLINICAL_TRIALS study record update · 2025-09-26A Pilot Study of Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
-
CLINICAL_TRIALS study record update · 2025-09-24Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Intensive Chemotherapy With or Without Hematopoietic Cell Transplantation, a Multicenter Cluster Randomized Study
-
CLINICAL_TRIALS study record update · 2025-09-19Feasibility of an Adapted Sports Program Based on Fencing to Reduce Physical Deconditioning in Adult Hematology Patients Receiving Intensive Treatment
-
CLINICAL_TRIALS study record update · 2025-09-18Pilot Test of a Pain Management Intervention Preparatory to a Future Pragmatic Trial (ASCENT)
-
CLINICAL_TRIALS study record update · 2025-09-18REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs
-
CLINICAL_TRIALS study record update · 2025-09-17A Multicenter, Open-label, Single-arm Phase Ib/IIa Clinical Study to Evaluate the Safety and Efficacy of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2025-09-17Supportive Transfusion Program for Patients With Hematologic Malignancies: A Cluster Randomized Trial
-
CLINICAL_TRIALS study record update · 2025-09-11A Phase 1, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of LB1410, A Recombinant Anti-PD-1 and Anti-TIM-3 Humanized Bispecific Antibody for Injection in Patients With Advanced Solid Tumors or Lymphoma（Keyplus-001）
-
CLINICAL_TRIALS study record update · 2025-09-04Value of Super-resolution Ultrasound Microvascular Imaging in Distinguishing Benign and Malignant Superficial Lymph Nodes: a Prospective Multi-center Study
-
CLINICAL_TRIALS study record update · 2025-09-02The Effects of Anthracycline-based Chemotherapy on Spontaneous Baroreflex Sensitivity, Carotid Artery Stiffness, and Endothelial-dependent Vascular Function.
-
CLINICAL_TRIALS study record update · 2025-08-26Randomized Study Comparing an Immuno-Chemotherapy With 6 Cycles of the Monoclonal Anti-CD20 Antibody Rituximab in Combination With 6 Cycles of Chemotherapy With CHOP ( Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) at 21-day Intervals or 14-day Intervals, Both With or Without Consolidating Radiotherapy or Large Tumour Masses (≥7.5 cm) and/or Extranodal Involvement in Patients With Aggressive CD20 B-Cell Lymphoma Aged 18 to 60 Years With Age-Adjusted IPI=1 (All) or IPI=0 With a Large Tumour Mass (≥7.5 cm) [UNFOLDER 21/14 Study]
-
CLINICAL_TRIALS study record update · 2025-08-26Enhanced Assistance During Radiotherapy for Unmet Essential Needs (EARN): a Single Center Hybrid Type 1 Efficacy-implementation Study
-
CLINICAL_TRIALS study record update · 2025-08-22A Pharmacokinetic and Pharmacodynamic Study of DZ-002 in Patients With Advanced Solid Malignancies or Lymphoma
-
CLINICAL_TRIALS study record update · 2025-08-22First in Human Safety of [68Ga]-NOTA-hGZP- PET Imaging in Subjects Receiving Checkpoint Inhibitor Immunotherapy